Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

Too much epidermal growth factor can cause hair loss.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

PRP helps skin heal, possibly through special cells called telocytes.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Vasodilators may worsen abdominal aortic aneurysm.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

Cucurbitacin helps mice grow hair by blocking a protein that stops hair growth.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.